Publications by authors named "Daniel Lebovic"

Claim this Profile
R
Real world evaluation of Evusheld in prevention of COVID-19 in immunocompromised patients: An observational cohort study.
Sarah Channey, Pramodini Kale-Pradhan, Mamta Sharma, Daniel Lebovic, Christopher Giuliano

Am J Med Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.
John Cafardi, Carole Miller, Howard Terebelo, Chad Tewell, Sadia Benzaquen, Daniel Lebovic

JAMA Netw Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choroidal effusion: a rare and unusual complication of daratumumab.
Aditi Singh, Talal Bazzi, Daniel Lebovic, Hakan Demirci

BMJ Case Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More than an Incidentaloma: The Nonreportable NIPT.
Allison M Jay, Brian Mason, Daniel Lebovic, Paul Chuba

Case Rep Obstet Gynecol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TdT Positive Lymphoma with MYC, BCL2 and BCL6 Rearrangements: A Review of Diagnosis and Treatment.
Aditi Singh, Ishaq Asghar, Laura Kohler, Daniel Snower, Hosam Hakim, Daniel Lebovic

Mediterr J Hematol Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma.
Paul G Richardson, Craig C Hofmeister, Cara A Rosenbaum, Myo Htut, David H Vesole, Daniel Lebovic

Br J Haematol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.
Paul G Richardson, William I Bensinger, Carol Ann Huff, Caitlin L Costello, Nikoletta Lendvai, Daniel Lebovic

Br J Haematol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Ranjana H Advani, Daniel Lebovic, Andy Chen, Mark Brunvand, Andre Goy

Clin Cancer Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sweet syndrome: a painful reality.
Uqba Khan, Humaira Rizvi, Farman Ali, Daniel Lebovic

BMJ Case Rep· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
Alexander M Lesokhin, Stephen M Ansell, Philippe Armand, Emma C Scott, Ahmad Halwani, Daniel Lebovic

J Clin Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.
Jatin J Shah, Andrzej J Jakubowiak, Owen A O'Connor, Robert Z Orlowski, R Donald Harvey, Daniel Lebovic

Clin Cancer Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab.
Rebecca L Elstrom, Jia Ruan, Paul J Christos, Peter Martin, Daniel Lebovic

Leuk Lymphoma· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma.
Dominik Dytfeld, Jagoda Jasielec, Kent A Griffith, Daniel Lebovic, David H Vesole

Haematologica· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.
Hongxiu Li, Mark S Kaminski, Yifeng Li, Mehmet Yildiz, Peter Ouillette, Daniel Lebovic

Blood· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.
Andrzej J Jakubowiak, Dominik Dytfeld, Kent A Griffith, Daniel Lebovic, David H Vesole

Blood· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of patients with plasma cell leukemia in the era of novel therapies and hematopoietic stem cell transplantation strategies: a single-institution experience.
Daniel Lebovic, Ling Zhang, Melissa Alsina, Taiga Nishihori, Kenneth H Shain

Clin Lymphoma Myeloma Leuk· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial.
Dominik Dytfeld, Kent A Griffith, Judah Friedman, Daniel Lebovic, Colleen Harvey

Leuk Lymphoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer after 70: is it a different disease?
Daniel J Lebovic, Tariq Mahmood, Alberto Chiappori

Oncology (Williston Park)· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis.
Rachid Baz, Mehul Patel, Elizabeth Finley-Oliver, Daniel Lebovic, Mohamad A Hussein

Leuk Lymphoma· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis